Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Hepy Biosciences

PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Manufacturer of a cancer care drug. The company develops a cancer drug that suppresses a certain enzyme activity in tumor responsible for its growth and for the development of secondary tumors.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Nes Ziona
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Hepy Biosciences’s full profile, request a free trial.

Hepy Biosciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 12-Jan-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Hepy Biosciences Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
FutuRx Accelerator/Incubator 000 0000 000000 0

Hepy Biosciences Executive Team (2)

Name Title Board
Seat
Contact
Info
Nili Schutz Chief Executive Officer
Oded Livnah Professor